East Palo Alto, CA, United States of America

Dan Cao

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dan Cao

Introduction

Dan Cao is an accomplished inventor based in East Palo Alto, California. He has made significant contributions to the field of biochemistry, particularly through his innovative patent related to biotin-streptavidin cleavage compositions. His work has implications for various applications in molecular biology and biotechnology.

Latest Patents

Dan Cao holds a patent for a biotin-streptavidin cleavage composition and library fragment cleavage. This patent describes a composition that includes a formamide reagent and a salt buffer. The formamide reagent is present in an amount ranging from about 10% to about 50% of the total volume of the composition. The salt buffer constitutes the remainder of the composition. This innovative cleavage composition is designed to cleave library fragments from a solid support, showcasing its potential utility in various scientific applications.

Career Highlights

Dan Cao is currently employed at Illumina Corporation, a leading company in the field of genomics and biotechnology. His work at Illumina has allowed him to further develop his expertise and contribute to groundbreaking advancements in genetic research and technology.

Collaborations

Dan has collaborated with notable colleagues, including Jeffrey S. Fisher and Fiona Kaper. These collaborations have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

Dan Cao's contributions to the field of biochemistry through his patent and work at Illumina Corporation highlight his role as a significant inventor. His innovative approaches continue to influence advancements in molecular biology and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…